Swissmedic公布eCTD v4.0实施时间表并发布瑞士实施指南1.1版
Swissmedic: eCTD v4.0
Swissmedic公布eCTD v4.0的实施与过渡安排,计划2026年底完成技术实施、2027年正式上线,过渡期内继续支持现行eCTD v3.2.2。Swissmedic已发布瑞士实施指南1.1版,并配套提供受控词汇(CV)1.1和验证标准v1.1文件下载。实施指南最终2.0版最迟计划于2027年初推出,试点研究完成后拟于2027年春季提供FAQ文件。
The eCTD format is a specific electronic submission format for applications related to drug approvals. It enables optimal management of drug dossiers and their lifecycle. eCTD is based on the definition of the Common Technical Document (CTD) with its five modules and complies with ICH Technical Specification V3.2.2. Module 1 is specific to Switzerland, while Modules 2–5 are internationally harmonized.The following guidance documents govern and describe the eCTD submission process to Swissmedic: Swiss M1 Specification for eCTD Swiss eCTD Validation Criteria Guidance for Industry Questions & Answers (Q&A on Swiss eCTD Implementation)When preparing a marketing authorization application in eCTD format for a medicinal product already authorized abroad, Guidance Paragraph 13 TPA must be followed. The applicant is required to validate the technical correctness of the electronic data in eCTD submissions in advance.eCTD v4.0 is a technical standard defined by the ICH for electronic marketing authorization submissions. It is a further development of eCTD v3.2.2, on which Swissmedic’s current eCTD solution is also based.Timeline & Transition Technical implementation by the end of 2026 Production launch in 2027 (following completion of pilot studies) eCTD v3.2.2 will continue to be supported during a multi-year transition phaseSwissmedic has also published the Swiss Implementation Guide (Version 1.1). It describes the technical requirements and serves as the basis for software that can be used to create valid submissions for Switzerland. In addition to the Implementation Guide, the documents “Controlled Vocabulary (CV) v1.1” and “Validation Criteria v1.1” are relevant. These files are available for download as a ZIP file on the Swissmedic website. Next Steps Requirements are being continuously refined in parallel with the development of the eCTD review solution; additional versions will follow as needed. A final Version 2.0 of the Swiss Implementation Guide is scheduled for early 2027 at the latest. Following the completion of the pilot studies, a FAQ document is to be made available in spring of 2027.
来源:ECA GMP News · gmp-compliance.org